IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING: federal award price forecast
Across 7,046 recent federal awards in NAICS 325413, the winning price typically lands between $495 and $375K, with a midpoint near $26K. AwardCast forecasts the closing price for a specific solicitation in this market.
Who wins in this market
| Contractor | Wins | Median award |
|---|---|---|
| ROCHE DIAGNOSTICS CORPORATION | 551 | $83K |
| BIOMERIEUX INC | 373 | $121K |
| CEPHEID | 355 | $208K |
| SIEMENS HEALTHCARE DIAGNOSTICS INC. | 324 | $35K |
| 10X GENOMICS, INC. | 260 | $24K |
Contractor profiles in this category
Solicitations in this category
Questions
What do federal contracts in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING pay?
Between $495 and $375K, with a midpoint near $26K, across 7,046 federal awards in NAICS 325413.
Which agencies buy IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING?
The largest buyers on record are Department Of Veterans Affairs, Department Of Health And Human Services.
Who wins contracts in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING?
ROCHE DIAGNOSTICS CORPORATION, BIOMERIEUX INC, CEPHEID are among the most frequent winners in this category.
Agencies buying in this category
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
$49 per report. No subscription, no account needed to see pricing.